Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 15587301000001115 | Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 15587401000001111 | Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 59645401000001116 | Ferrous sulphate 325mg / Ascorbic acid 500mg modified-release tablets | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 75181601000001119 | Ferrous sulfate 325mg / Ascorbic acid 500mg modified-release tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ferrograd C modified-release tablets (Teofarma S.r.l.) | Is a | True | Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets 30 tablet | Is pack of | False | Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets 30 tablet | Has VMP | True | Ascorbic acid 500mg / Ferrous sulphate 325mg modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets